Improved visual hallucination by donepezil and occipital glucose metabolism in dementia with lewy bodies: The Osaki-Tajiri project

European Neurology

Volumn 64, Issue 6, 2010, Pages 337-344

  Satoh, Masayuki ^a   Ishikawa, Hiroyasu ^a   Meguro, Kenichi ^a,b   Kasuya, Masashi ^a   Ishii, Hiroshi ^a,c   Yamaguchi, Satoshi ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaki Tajiri SKIP Center   (Japan)

^c Kawasaki Kokoro Hospital   (Japan)

Author keywords

Dementia with Lewy bodies; Positron emission tomography; Regional cerebral metabolic rates of glucose; Visual hallucinations

Indexed keywords

DONEPEZIL; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; GERMANIUM 68; UNCLASSIFIED DRUG;

AGED; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; DEMENTIA; DISEASE ASSOCIATION; FEMALE; GLUCOSE METABOLISM; HUMAN; LEWY BODY; MALE; OCCIPITAL CORTEX; POSITRON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VISUAL HALLUCINATION;

AGED, 80 AND OVER; FEMALE; GLUCOSE; HALLUCINATIONS; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INDANS; LEWY BODY DISEASE; MALE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; OCCIPITAL LOBE; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY;

EID: 78149291467     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322121     Document Type: Article

References (26)

1. Ishii K, Hosaka K, Mori T, Mori E: Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies. Ann Nucl Med 2004; 18: 447-451.
2. Matsui Y, Tanizaki Y, Arima H, Yonemoto K, Doi Y, Ninomiya T, Sasaki K, Iida M, Iwaki T, Kanba S, Kiyohara Y: Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama study. J Neurol Neurosurg Psychiatry 2009; 80: 366-370.
3. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies: report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
4. O'Brien JT, Firbank MJ, Mosimann UP, Burn DJ, McKeith IG: Change in perfusion, hallucination and fluctuation in consciousness in dementia with Lewy bodies. Psychiatry Res 2005; 139: 79-88.
5. Aarsland D, Hutchinson M, Larsen JP: Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003; 18: 937-941.
6. Minett TS, Thomas A, Wilkinson LM, Daniel SL, Sanders J, Richardson J, Littlewood E, Myint P, Newby J, McKeith IG: What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2003; 18: 988-993.
7. Mori T, Ikeda M, Fukuhara R, Nestor PJ, Tanabe H: Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology 2006; 66: 935-937.
8. Kemp PM, Holmes C: Imaging in dementia with Lewy bodies: a review. Nucl Med Commun 2007; 28: 511-519.
9. Hanyu H, Shimizu S, Hirao K, Kanetaka H, Iwamoto T, Chikamori T, Usui Y, Yamashina A, Koizumi K, Abe K: Comparative value of brain perfusion SPECT and [ 123 I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006; 33: 248-253.
10. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, McKeith IG, O'Brien JT: Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643-649. (Pubitemid 32209999)
11. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
12. Reisberg B, Borenstein J, Fransses E, et al: BEHAVE-AD: a clinical rating scale for the assessment of pharmacologically remediable behavioral symptomatology in Alzheimer's disease; in Altman HJ (ed): Alzheimer's Disease: Problems, Prospects and Perspectives. New York, Plenum, 1987, pp 1-16.
13. Fujiwara T, Watanuki S, Yamamoto S, Miyake M, Seo S, Itoh M, Ishii K, Orihara H, Fukuda H, Satoh T, Kitamura K, Tanaka K, Takahashi S: Performance evaluation of a large axial field-of-view PET scanner: SET- 2400W. Ann Nucl Med 1997; 11: 307-313.
14. Wakita K, Imahori Y, Ido T, et al: Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. J Nucl Med 2000; 41: 1484-1490.
15. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE: Tomographic measurement of local glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy- D -glucose: validation of method. Ann Neurol 1979; 6: 371-388.
16. Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, Yamadori A: Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 1997; 62: 596-600.
17. Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S: Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project. Int Psychogeriatr 2009; 21: 148-156.
18. Yong SW, Yoon JK, An YS, Lee PH: A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies. Eur J Neurol 2007; 14: 1357-1362.
19. Lance JW: Simple formed hallucinations confined to the area of a specific visual field defect. Brain 1976; 99: 719-734.
20. Perneczky R, Drzezga A, Boecker H, Förstl H, Kurz A, Häussermann P: Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations. New York, Plenum
21. Nagahama Y, Okina T, Suzuki N, Matsuda M: Neural correlates of psychotic symptoms in dementia with Lewy bodies. Brain 2010; 133: 557-567.
22. Tune L, Tiseo PJ, Ieni J, Perdomo C, Pratt RD, Votaw JR, Jewart RD, Hoffman JM: Donepezil HCl (E2020) maintains functional brain activity in patients with Alzheimer disease: results of a 24-week, double-blind, placebocontrolled study. Am J Geriatr Psychiatry 2003; 11: 169-177.
23. Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E: Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies. Neuroreport 1999; 10: 1903-1907. (Pubitemid 29331747)
24. Barinaga M: The cerebellum: movement coordinator or much more? Science 1996; 272: 482-483.
25. Schmahmann JD, Sherman JC: The cerebellar cognitive affective syndrome. Brain 1998; 121: 561-579.
26. Miyazawa N, Shinohara T, Nagasaka T, Hayashi M: Hypermetabolism in patients with dementia with Lewy bodies. Clin Nucl Med 2010; 35: 490-493.